Arca
Skip to content
Tools
Tools

IL17RA: Interleukin-17 receptor A

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity.

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it.
DrugUS approvalMechanismActionWarnings
BrodalumabApprovedInterleukin-17 receptor A antagonistAntagonistBoxed warning

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Immunodeficiency 51
0.74
Chronic mucocutaneous candidiasis
0.61
Psoriasis vulgaris
0.58
Pustular psoriasis
0.51
Immune system disorder
0.37
Polycythemia
0.18

Drugs and mechanisms are from ChEMBL CHEMBL3580485 (CC BY-SA 3.0). Gene name, function (UniProt Q96F46, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.